首页> Blood advances> Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy.

Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Peter G,Miller

第一单位： Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.;Broad Institute of MIT and Harvard, Cambridge, MA.

作者： Peter G,Miller ^[1] ; Adam S,Sperling ^[2] ; Elliott J,Brea ^[3] ; Mark B,Leick ^[4] ; Geoffrey G,Fell ^[5] ; Max,Jan ^[6] ; Satyen H,Gohil ^[7] ; Yu-Tzu,Tai ^[3] ; Nikhil C,Munshi ^[3] ; Catherine J,Wu ^[1] ; Donna S,Neuberg ^[5] ; Marcela V,Maus ^[4] ; Caron,Jacobson ^[3] ; Christopher J,Gibson ^[1] ; Benjamin L,Ebert ^[8]

作者单位： Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.;Broad Institute of MIT and Harvard, Cambridge, MA. ^[1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.;Division of Hematology, Brigham and Women's Hospital, Boston, MA. ^[2] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. ^[3] Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA. ^[4] Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA. ^[5] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.;Broad Institute of MIT and Harvard, Cambridge, MA.;Department of Pathology, Massachusetts General Hospital, Boston, MA. ^[6] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.;Broad Institute of MIT and Harvard, Cambridge, MA.;Department of Academic Haematology, University College London Cancer Institute, London, United Kingdom; and. ^[7] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.;Broad Institute of MIT and Harvard, Cambridge, MA.;Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston, MA. ^[8]

医学主题词人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);中年人(Middle Aged)

DOI 10.1182/bloodadvances.2021004554

PMID 34342642

发布时间 2024-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood advances

2021年5卷15期

2982-2986页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Blood advances

2021年5卷15期

2982-2986页

检索历史清除

Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

检索历史清除